Altre lingue Amicogen, Inc.

Azioni

A092040

KR7092040005

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 20/05/2024			Variaz. 5gg	Var. 1 gen.
7.210 ^KRW	-2,44%		-0,41%	-4,63%

20/03	Amicogen, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Amicogen, Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Fonds Small & Midcaps : Poursuite du rattrapage des petites cap’	18/05
Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Beyond Cells announced that it has received KRW 3 billion in funding from Amicogen, Inc.	15/04/23
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22
Lysando Ag and Amicogen Inc. Sign General Development Agreement	18/10/22
Amicogen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
Amicogen, Inc. announced that it expects to receive KRW 40 billion in funding	18/07/22
Amicogen, Inc. announced that it expects to receive KRW 40 billion in funding	18/07/22
Amicogen, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Amicogen, Inc. announced that it has received KRW 8.7 billion in funding	11/05/22
Amicogen, Inc. announced that it expects to receive KRW 8.7 billion in funding	09/05/22
Amicogen, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22/03/22
Amicogen, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15/11/21
Amicogen, Inc. completed the acquisition of 30% stake in BIFIDO Co., Ltd from a group of shareholders.	14/09/21
Bio Works Technologies : Amicogen Inc enters into agreement to divest its ownership in Bio-Works	10/09/21
Amicogen, Inc. announced that it has received KRW 22.2724863 billion in funding from Lysando AG	02/09/21
Amicogen, Inc. agreed to acquire a 30% stake in BIFIDO Co., Ltd from a group of shareholders for KRW 60.1 billion.	21/07/21

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Amicogen, Inc.

Azioni

A092040

KR7092040005

Altre lingue

Filtri